Johnson And Johnson Vaccine
- All
- News
- Videos
-
US Limits Johnson & Johnson Covid Vaccine Use Over Rare Blood Clot Risk
The US said Thursday only adults who "have personal concerns" about mRNA vaccines, access issues or medical reasons for refusing them may now receive the Johnson & Johnson Covid shot, which has been linked to a rare but serious clotting condition.
-
J&J Vaccine Gets Additional Warning On Bleeding Side Effect
The fact sheet for Johnson & Johnson's Covid-19 vaccine has been revised by U.S. regulators to warn of the risk of a rare bleeding disorder.
-
US Panel Recommends mRNA COVID-19 Vaccines Over Johnson & Johnson
A US government-appointed panel of medical experts on Thursday unanimously recommended mRNA Covid vaccines made by Pfizer and Moderna over Johnson & Johnson's shot, in light of its weaker protection and greater risks.
-
UK Advises Work From Home, Mandates Vaccine Passports Amid Omicron Surge
British Prime Minister Boris Johnson on Wednesday announced the tightening of virus restrictions in England as Omicron variant cases surge, including guidance to work from home and mandatory vaccine passports.
-
Cause Of Rare Blood Clots Linked With AstraZeneca, Johnson & Johnson Covid Vaccines Found: Study
Scientists have found a possible trigger behind the extremely rare blood clots linked to AstraZeneca and Johnson & Johnson COVID-19 vaccines, an advance that may help design new and improved preventives against the viral disease.
-
Boris Johnson On "Best" Single Defence Against Covid Variant Omicron
Booster COVID-19 vaccines increase the body's immune response and remain the best single defence against the new Omicron variant of coronavirus, British Prime Minister Boris Johnson said on Tuesday.
-
US Allows Mix-And-Match Booster For Pfizer, Moderna, J&J Covid Vaccines
The US Food and Drug Administration (FDA) on Wednesday authorized using a so-called "mix and match" strategy for eligible people who require a booster shot of a Covid vaccine after their primary series.
-
US Panel Recommends Johnson & Johnson Vaccine Booster With 2-Month Gap
A high level panel of US medical experts voted unanimously Friday to recommend authorizing a second shot of the Johnson & Johnson Covid vaccine.
-
PM Modi, UK's Johnson Speak As UK Ends Quarantine For Vaccinated Indian Travellers
PM Narendra Modi and Boris Johnson welcomed the UK's recognition of Indian vaccine certification and agreed on the need for a coordinated international approach.
-
Johnson & Johnson Asks US To Authorise Booster Shots Of Covid Vaccine
Drug maker Johnson & Johnson asked the US Food and Drug Administration (FDA) on Tuesday to authorize booster shots of its Covid-19 vaccine for people over the age of 18.
-
Johnson & Johnson Seeks Nod For Vaccine Trials For 12-17 Group In India
Johnson & Johnson has applied for permission to conduct COVID-19 vaccine trials in India on children in the 12-17 age group, saying it is critical that "all sections of the population" are vaccinated to ensure achievement of herd immunity status.
-
Still In Talks With India Over COVID-19 Vaccine: Johnson & Johnson
India's drug regulator said on Monday that Johnson & Johnson withdrew its proposal seeking accelerated approval of its COVID-19 vaccine in the country, without giving additional details, according to a report by news agency Reuters.
-
Johnson & Johnson Forecasts $2.5 Billion In COVID-19 Vaccine Sales
Johnson & Johnson on Wednesday forecast just $2.5 billion in 2021 sales of its COVID-19 vaccine, which has fallen way behind rival shots from Pfizer and Moderna as the company deals with vaccine production issues and safety concerns.
-
France Recognises Covishield For Vaccine Pass, Tightens Travel Rules
France will consider people fully vaccinated one week after they received their second dose of the Pfizer/BioNTech, Moderna and AstraZeneca shots, instead of 14 days previously, and 28 days after their Johnson & Johnson jab.
-
J&J's Covid Shot Gets US Regulator Warning About Rare Immune Disorder
The fact sheet for Johnson & Johnson's Covid-19 vaccine was revised to warn of the risk of a rare immune-system disorder, adding new headwinds for a shot once expected to be a linchpin of the US immunization effort.
-
US Limits Johnson & Johnson Covid Vaccine Use Over Rare Blood Clot Risk
The US said Thursday only adults who "have personal concerns" about mRNA vaccines, access issues or medical reasons for refusing them may now receive the Johnson & Johnson Covid shot, which has been linked to a rare but serious clotting condition.
-
J&J Vaccine Gets Additional Warning On Bleeding Side Effect
The fact sheet for Johnson & Johnson's Covid-19 vaccine has been revised by U.S. regulators to warn of the risk of a rare bleeding disorder.
-
US Panel Recommends mRNA COVID-19 Vaccines Over Johnson & Johnson
A US government-appointed panel of medical experts on Thursday unanimously recommended mRNA Covid vaccines made by Pfizer and Moderna over Johnson & Johnson's shot, in light of its weaker protection and greater risks.
-
UK Advises Work From Home, Mandates Vaccine Passports Amid Omicron Surge
British Prime Minister Boris Johnson on Wednesday announced the tightening of virus restrictions in England as Omicron variant cases surge, including guidance to work from home and mandatory vaccine passports.
-
Cause Of Rare Blood Clots Linked With AstraZeneca, Johnson & Johnson Covid Vaccines Found: Study
Scientists have found a possible trigger behind the extremely rare blood clots linked to AstraZeneca and Johnson & Johnson COVID-19 vaccines, an advance that may help design new and improved preventives against the viral disease.
-
Boris Johnson On "Best" Single Defence Against Covid Variant Omicron
Booster COVID-19 vaccines increase the body's immune response and remain the best single defence against the new Omicron variant of coronavirus, British Prime Minister Boris Johnson said on Tuesday.
-
US Allows Mix-And-Match Booster For Pfizer, Moderna, J&J Covid Vaccines
The US Food and Drug Administration (FDA) on Wednesday authorized using a so-called "mix and match" strategy for eligible people who require a booster shot of a Covid vaccine after their primary series.
-
US Panel Recommends Johnson & Johnson Vaccine Booster With 2-Month Gap
A high level panel of US medical experts voted unanimously Friday to recommend authorizing a second shot of the Johnson & Johnson Covid vaccine.
-
PM Modi, UK's Johnson Speak As UK Ends Quarantine For Vaccinated Indian Travellers
PM Narendra Modi and Boris Johnson welcomed the UK's recognition of Indian vaccine certification and agreed on the need for a coordinated international approach.
-
Johnson & Johnson Asks US To Authorise Booster Shots Of Covid Vaccine
Drug maker Johnson & Johnson asked the US Food and Drug Administration (FDA) on Tuesday to authorize booster shots of its Covid-19 vaccine for people over the age of 18.
-
Johnson & Johnson Seeks Nod For Vaccine Trials For 12-17 Group In India
Johnson & Johnson has applied for permission to conduct COVID-19 vaccine trials in India on children in the 12-17 age group, saying it is critical that "all sections of the population" are vaccinated to ensure achievement of herd immunity status.
-
Still In Talks With India Over COVID-19 Vaccine: Johnson & Johnson
India's drug regulator said on Monday that Johnson & Johnson withdrew its proposal seeking accelerated approval of its COVID-19 vaccine in the country, without giving additional details, according to a report by news agency Reuters.
-
Johnson & Johnson Forecasts $2.5 Billion In COVID-19 Vaccine Sales
Johnson & Johnson on Wednesday forecast just $2.5 billion in 2021 sales of its COVID-19 vaccine, which has fallen way behind rival shots from Pfizer and Moderna as the company deals with vaccine production issues and safety concerns.
-
France Recognises Covishield For Vaccine Pass, Tightens Travel Rules
France will consider people fully vaccinated one week after they received their second dose of the Pfizer/BioNTech, Moderna and AstraZeneca shots, instead of 14 days previously, and 28 days after their Johnson & Johnson jab.
-
J&J's Covid Shot Gets US Regulator Warning About Rare Immune Disorder
The fact sheet for Johnson & Johnson's Covid-19 vaccine was revised to warn of the risk of a rare immune-system disorder, adding new headwinds for a shot once expected to be a linchpin of the US immunization effort.
